Based on ratings from 9 stock analysts, the Bio-Techne Corp stock price is expected to increase by 21.16% in 12 months. This is calculated by using the average 12-month stock price forecast for Bio-Techne Corp. The lowest target is $66.00 and the highest is $95.00. Please note analyst price targets are not guaranteed and could be missed completely.
About 9 Wall Street analysts have assignedTECH 7 buy ratings, 2 hold ratings, and 0 sell ratings. This means that analysts expect Bio-Techne Corp to buy. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on TECH. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
---|---|---|---|---|
alexander nowak Craig-Hallum | Buy | $80.0 | rated | Feb 2, 2024 |
robert wasserman Benchmark Co. | Buy | $95.0 | maintained | Feb 2, 2024 |
jacob johnson Stephens | Buy | $87.0 | maintained | Feb 2, 2024 |
conor mcnamara RBC Capital | Hold | $75.0 | maintained | Feb 1, 2024 |
david toung Argus Research | Buy | $90.0 | maintained | Jan 4, 2024 |
justin bowers Deutsche Bank | Buy | $88.0 | maintained | Dec 18, 2023 |
douglas harter UBS | Buy | $80.0 | initiatedcoverage | Dec 7, 2023 |
timothy daley Wells Fargo | Hold | $66.0 | maintained | Nov 14, 2023 |
patrick b donnelly Citi | Buy | $80.0 | maintained | Nov 13, 2023 |
daniel arias Stifel Nicolaus | Buy | $65.0 | maintained | Nov 2, 2023 |
paul knight KeyBanc | Buy | $80.0 | maintained | Nov 1, 2023 |
puneet souda Leerink Partners | Buy | $90.0 | reiterated | Oct 31, 2023 |
catherine ramsey schulte Robert W. Baird | Buy | $68.0 | maintained | Oct 31, 2023 |
matt larew William Blair | Buy | None | initiatedcoverage | Aug 28, 2023 |
dan leonard Credit Suisse | Buy | $116.25 | initiatedcoverage | Aug 24, 2022 |
abhinandan agarwal Deutsche Bank | Buy | $50.0 | maintained | Mar 10, 2022 |
drew jones Stephens | Hold | $273.0 | downgraded | Jul 15, 2020 |
ralph m. profiti Eight Capital | Hold | None | downgraded | Feb 24, 2020 |
matt hewitt Craig-Hallum | Hold | $154.0 | downgraded | Oct 31, 2018 |
john staszak Argus Research | Buy | $230.0 | maintained | Oct 2, 2018 |
In 2023, TECH generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that TECH's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2019
Revenue From 2020
Revenue From 2021
Revenue From 2022
SPLK-USD
$154.42
TEAM-USD
$216.17
TXN-USD
$162.4
UPST-USD
$33.9
TXG-USD
$49.11
TWKS-USD
$4.41